Developmental Traumatology: Complex Trauma, Social Pragmatic Communication, and the Speech, Language, Hearing Scientist – Yvette D. Hyter, Ph.D., CCC-SLP

by ISTSS Blogs | Sep 30, 2021 | Clinical Issues and Treatment, StressPoints

I have worked as a speech, language and hearing (SLH) scientist for 37 years, a discipline traditionally referred to speech-language pathology, but “pathology” implies an ableist perspective (Nielsen, 2021), prompting my use of a different nomenclature....

Shame Mediates Emotion Dysregulation and PTSD Symptoms in Combat Veterans – Aidan Flynn, MS, Alexander Puhalla, PhD, & Amanda Vaught, PsyD

by ISTSS Blogs | Aug 30, 2021 | Clinical Issues and Treatment, Military and Combat

Posttraumatic stress disorder (PTSD) is one of the most prevalent mental health disorders among US veterans (Magruder et al., 2005) and is associated with emotion dysregulation (i.e., an inability to effectively respond to emotional experiences; Gratz & Roemer,...

How has the COVID-19 pandemic impacted patients receiving PTSD care? – Carmen McLean, PhD, Sonya Norman, PhD, & Sudie Back, PhD

by ISTSS Blogs | Aug 16, 2021 | Clinical Issues and Treatment, COVID-19

One of the biggest changes to the mental health landscape since the onset of the pandemic has been the rapid and wide-scale switch from in-person therapy to telehealth. The adoption of telehealth may represent a silver lining to the pandemic, insofar as telehealth can...

Clinician’s Corner: The Transcending Trauma Project, Part II: ‎A Systemic Perspective Of Coping and Adaptation: The Inextricable Connection Between ‎Individual and Family – Bea Hollander-Goldfein, PhD

by ISTSS Blogs | Jul 29, 2021 | Clinical Issues and Treatment, StressPoints

As discussed in the last issue of ISTSS StressPoints’ Clinician’s Corner column, in 1993, the Transcending Trauma Project (TTP) was launched under the auspices of the Council for Relationships, affiliated with Jefferson University, and located in...

Biological Perspectives: Psychedelic Drugs for the Treatment of Trauma-Related Disorders – Jack C. Lennon, MA

by ISTSS Blogs | Jul 23, 2021 | Clinical Issues and Treatment, StressPoints

Psychedelic drugs, including but not limited to psilocybin, lysergic acid diethylamide (LSD), methylenedioxy-methylamphetamine (MDMA), peyote and dimethyltryptamine (DMT), are currently classified by the U.S. Drug Enforcement Administration (DEA) as Schedule 1...

MDMA-Assisted Therapy can improve Sleep Quality in PTSD – Linnae Ponte and Lisa Jerome

by ISTSS Blogs | Jun 14, 2021 | Clinical Issues and Treatment, JOTS Highlights

Recent advances in sleep research have shown that overall sleep quality is associated with a person’s physical and mental wellbeing (Tahmasian et al., 2020). As such, sleep disturbances are a common feature of many mental disorders, including posttraumatic...